Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Small Doses of Thyroxine in Type 2 Diabetes
NCT02509858Completed
- Sponsor
- Attikon University Hospital
- Start
- Feb 2009
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of levothyroxine sodium in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Attikon University Hospital. Primary endpoint: Area Under the Glucose Uptake versus Time Curve. Started Feb 2009; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02509858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02509858.